Thousands of bottles of a common blood pressure drug were pulled because the tablets may not break down the way they should.
Quick Take
- The Food and Drug Administration recalled 11,460 bottles of chlorthalidone nationwide due to failed dissolution testing.[1][2]
- The affected products are 25-milligram tablets in 100-count and 1,000-count bottles from Inventia Healthcare Limited.[1][2]
- The concern is not that the pills were found to be poison. The concern is that they may not dissolve properly, which can weaken the dose a patient gets.[2][4]
- The FDA has not yet assigned a specific recall class or provided detailed consumer instructions beyond contacting a health care professional.[2]
What Was Recalled and Why It Matters
The recall covers 100-tablet bottles marked with code 64980-599-01 and batch number RISA24001, plus 1,000-tablet bottles marked with code 64980-599-10 and batch number RISB24002.[1] Both versions carry an April 2027 expiration date.[1]
The core issue is dissolution, which is a drug-maker term for how well a tablet breaks apart and releases its medicine in the body. If that step fails, the pill may not deliver the full intended effect.[2][4]
That is why this recall draws attention fast. Blood pressure medicine is not a luxury item. Many patients take it every day, often for years, and they count on stable dosing.
A tablet that does not dissolve properly may leave a person undertreated without any obvious warning sign. That makes this kind of recall feel quiet on the surface, but serious underneath.
How Big the Recall Is
Public reports say the recall affects more than 11,000 bottles sold across the United States.[1][2][4] The products were distributed by Rising Pharma Holdings, Inc., which helped bring the medication to market.[1]
The scale matters because a nationwide recall can reach pharmacies, wholesalers, and homes simultaneously. For a patient, that means the correct next step starts with the bottle in hand, not with panic or guesswork.
The FDA’s own consumer guidance on recalls says patients should check the lot number on the label and compare it with the recall notice.[10] The agency also says consumers may learn about a recall through the news, a pharmacy, a doctor, or the manufacturer.[10]
In plain terms, the safest move is to verify the exact bottle before making any changes. That keeps people from tossing medicine they still need or from keeping medicine that belongs in the recall.
Why This Recall Feels Bigger Than a Routine Label Problem
This is not a packaging mistake or a typo on a box. It is a quality problem tied to how the drug behaves after it is swallowed.[2][8] That is a more unsettling kind of defect because the bottle can look normal while the medicine inside still falls short.
The FDA also says failed dissolution specifications have been a leading cause of recalls in recent years, indicating this is part of a broader manufacturing pattern rather than a one-off oddity.[13]
The recall applies to 100- and 1,000-tablet bottles of Chlorthalidone sold nationwide because they “failed dissolution specifications,” according to the Food and Drug Administration. https://t.co/MxbeGl9O6f
— WRBL News 3 (@wrblnews3) June 22, 2026
The broader lesson is simple: modern drug recalls often start long before anyone gets sick. They are usually prevention moves, not injury reports.[10][11]
That can make the public uneasy, because the warning sounds alarming while the harm remains only possible, not proven. Still, the logic is sound. If a tablet may not release its dose correctly, regulators do not wait for a trail of bad outcomes before acting.
For patients who own the affected chlorthalidone bottles, the practical step is to contact a pharmacist or prescriber and confirm what to do next.[1][2]
The FDA has not posted detailed return steps in the available reporting, so patients should not improvise by stopping or restarting treatment on their own.[2]
Blood pressure control is too important to rely on guesswork. The bottle number matters. The batch number matters. And in recalls like this, those small details decide whether a person is affected at all.
Sources:
[1] Web – Thousands of bottles of blood pressure medication recalled nationwide
[2] Web – FDA Announces Recall of Common Blood Pressure Medication
[4] Web – The recall applies to 100- and 1,000-tablet bottles of Chlorthalidone …
[8] Web – Blood pressure medication recalled nationwide over manufacturing …
[10] Web – More than 11K bottles of blood pressure drug recalled
[11] Web – Drug Recall Report – Washington State Local Health Insurance
[13] Web – The FDA recalled 11,460 bottles of chlorthalidone tablets, USP, 25 …














